Femara (letrozole) is a brand-name oral tablet prescribed for treating certain types of breast cancer. Femara has interactions with some other drugs, such as tamoxifen (Soltamox), and DHEA ...

Femara (letrozole) is a prescription drug used to treat certain types of breast cancer in people who have gone through menopause. The drug comes as an oral tablet. Femara is not safe to take while ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...

Findings from the NATALEE trial show that the combination of Kisqali and an aromatase inhibitor resulted in disease-free ...

Femara: 2.5mg once daily throughout the 28-day cycle. Pre/perimenopausal women: also treat with LHRH agonist. Concomitant strong CYP3A4 inhibitors: avoid; if coadmin necessary, reduce Kisqali to ...

Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

Audrey, who in 2017 had taken Femara — a medication used to induce ovulation in women with infertility — initially dismissed Crawford's suggestion, thinking she was unlikely to be pregnant.

The FDA on Tuesday approved ribociclib (Kisqali) in combination with endocrine therapy as adjuvant treatment for early ...

Will taking Kisqali with Femara increase my risk of certain side effects? It’s possible that taking Kisqali with Femara (letrozole) may increase the risk of certain side effects. In studies of ...

Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment ...